Literature DB >> 25630918

Percutaneous tibial nerve stimulation and sacral neuromodulation: an update.

Priyanka Gupta1, Michael J Ehlert, Larry T Sirls, Kenneth M Peters.   

Abstract

Neuromodulation is an important treatment modality for a variety of pelvic floor disorders. Percutaneous tibial nerve stimulation (PTNS) and sacral neuromodulation (SNM) are currently the two approved methods for delivering this therapy. Percutaneous tibial nerve stimulation is a minimally invasive office-based procedure that has shown efficacy in the treatment of overactive bladder, fecal incontinence, and pelvic pain. It has the advantage of minimal side effects but is limited by the need for patients to make weekly office visits to receive the series of treatments. Sacral neuromodulation uses an implanted device that stimulates the S3 nerve root and can improve symptoms of overactive bladder, non-obstructive urinary retention, fecal incontinence, and pelvic pain. This paper will review the most recent literature regarding this topic and discuss their advantages and limitations and recent innovations in their use.

Entities:  

Mesh:

Year:  2015        PMID: 25630918     DOI: 10.1007/s11934-014-0479-1

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  34 in total

1.  Sacral neuromodulation for nonobstructive urinary retention: a meta-analysis.

Authors:  Carey Gross; Mounira Habli; Christopher Lindsell; Mary South
Journal:  Female Pelvic Med Reconstr Surg       Date:  2010-07       Impact factor: 2.091

2.  Cost-effectiveness of test phase implantation strategies for InterStim® sacral neuromodulation.

Authors:  Kelly L Kantartzis; Jonathan P Shepherd
Journal:  Female Pelvic Med Reconstr Surg       Date:  2013 Nov-Dec       Impact factor: 2.091

3.  Outcomes associated with Interstim therapy for medically refractory fecal incontinence.

Authors:  M Shane McNevin; Michael Moore; Timothy Bax
Journal:  Am J Surg       Date:  2014-03-12       Impact factor: 2.565

4.  Quality of life is markedly improved in patients with fecal incontinence after sacral nerve stimulation.

Authors:  Ghislain Devroede; Chad Giese; Steven D Wexner; Anders Mellgren; John A Coller; Robert D Madoff; Tracy Hull; Katherine Stromberg; Sudha Iyer
Journal:  Female Pelvic Med Reconstr Surg       Date:  2012 Mar-Apr       Impact factor: 2.091

5.  Percutaneous tibial nerve stimulation effects on detrusor overactivity incontinence are not due to a placebo effect: a randomized, double-blind, placebo controlled trial.

Authors:  Enrico Finazzi-Agrò; Filomena Petta; Francesco Sciobica; Patrizio Pasqualetti; Stefania Musco; Pierluigi Bove
Journal:  J Urol       Date:  2010-09-20       Impact factor: 7.450

6.  PNE versus 1st stage tined lead procedure: a direct comparison to select the most sensitive test method to identify patients suitable for sacral neuromodulation therapy.

Authors:  Randall K Leong; Stefan G G De Wachter; F H M Nieman; Rob A de Bie; Philip E V van Kerrebroeck
Journal:  Neurourol Urodyn       Date:  2011-03-14       Impact factor: 2.696

Review 7.  Efficacy and adverse events of sacral nerve stimulation for overactive bladder: A systematic review.

Authors:  Nazema Y Siddiqui; Jennifer M Wu; Cindy L Amundsen
Journal:  Neurourol Urodyn       Date:  2010       Impact factor: 2.696

8.  Sacral nerve stimulation for voiding dysfunction: One institution's 11-year experience.

Authors:  Suzette E Sutherland; Ann Lavers; Angeline Carlson; Cindy Holtz; Jyothi Kesha; Steven W Siegel
Journal:  Neurourol Urodyn       Date:  2007       Impact factor: 2.696

9.  Challenges for managing overactive bladder and guidance for patient support.

Authors:  Vernon F Schabert; Tamara Bavendam; Erica L Goldberg; Jeffrey N Trocio; Linda Brubaker
Journal:  Am J Manag Care       Date:  2009-03       Impact factor: 2.229

10.  Cost of neuromodulation therapies for overactive bladder: percutaneous tibial nerve stimulation versus sacral nerve stimulation.

Authors:  Melissa Martinson; Scott MacDiarmid; Edward Black
Journal:  J Urol       Date:  2012-11-20       Impact factor: 7.450

View more
  20 in total

1.  Ultracompliant Carbon Nanotube Direct Bladder Device.

Authors:  Dongxiao Yan; Tim M Bruns; Yuting Wu; Lauren L Zimmerman; Chris Stephan; Anne P Cameron; Euisik Yoon; John P Seymour
Journal:  Adv Healthc Mater       Date:  2019-09-25       Impact factor: 9.933

Review 2.  Neurophysiology and neural engineering: a review.

Authors:  Arthur Prochazka
Journal:  J Neurophysiol       Date:  2017-05-31       Impact factor: 2.714

3.  Medium-term outcome of percutaneous tibial nerve stimulation in the treatment of fecal incontinence.

Authors:  M Hidalgo-Pujol; V Andriola; L M Jimenez-Gomez; F Ostiz; E Espin
Journal:  Tech Coloproctol       Date:  2018-12-18       Impact factor: 3.781

Review 4.  Electrical neuromodulation in the management of lower urinary tract dysfunction: evidence, experience and future prospects.

Authors:  Alejandro Abello; Anurag K Das
Journal:  Ther Adv Urol       Date:  2018-02-22

5.  Long-term efficacy of percutaneous tibial nerve stimulation for faecal incontinence and a new approach for partial responders.

Authors:  M Bosch-Ramírez; L Sánchez-Guillén; M J Alcaide-Quirós; M M Aguilar-Martínez; M Bellón-López; A López Delgado; F López-Rodríguez-Arias; A Muñoz-Duyos; X Barber-Valles; A Arroyo
Journal:  Tech Coloproctol       Date:  2022-10-12       Impact factor: 3.699

6.  Reply to "Pelvic floor dysfunction and chronic anal fissure: a dog chasing its tail".

Authors:  D A van Reijn-Baggen; H W Elzevier; R C M Pelger; I J M Han-Geurts
Journal:  Tech Coloproctol       Date:  2022-09-23       Impact factor: 3.699

7.  Short-term results of the efficacy of percutaneous tibial nerve stimulation on urinary symptoms and its financial cost.

Authors:  Zehra Kurdoğlu; Danielle Carr; Jihad Harmouche; Serdar Ünlü; Gökhan S Kılıç
Journal:  J Turk Ger Gynecol Assoc       Date:  2018-03-01

8.  A novel combined anorectal biofeedback and percutaneous tibial nerve stimulation protocol for treating fecal incontinence.

Authors:  Yoav Mazor; Gillian M Prott; Carol Sequeira; Michael Jones; Anastasia Ejova; John E Kellow; Margaret Schnitzler; Allison Malcolm
Journal:  Therap Adv Gastroenterol       Date:  2020-06-10       Impact factor: 4.409

9.  Transcutaneous Electrical Nerve Stimulation to Improve Female Sexual Dysfunction Symptoms: A Pilot Study.

Authors:  Lauren L Zimmerman; Priyanka Gupta; Florence O'Gara; Nicholas B Langhals; Mitchell B Berger; Tim M Bruns
Journal:  Neuromodulation       Date:  2018-09-03

10.  High Frequency Stimulation of the Pelvic Nerve Inhibits Urinary Voiding in Anesthetized Rats.

Authors:  Jonathan J Crook; Thelma A Lovick
Journal:  Front Physiol       Date:  2017-08-28       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.